Patent · US Expired

Nonpeptide substituted spirobenzoazepines as vasopressin antagonists

US7001898B2 · kind B2 · utility

4Cited by
6References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2001
Grant dateFeb 21, 2006
Priority date—
Expiry dateApr 27, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention is directed to nonpeptide substituted benzodiazepines of Formula I, wherein A, X, n, R1, R2, R3, R4, R5, a and b are as described in the specification, which are useful as vasopressin receptor antagonists for treating conditions associated with vasopressin receptor activity such as those involving increased vascular resistance and cardiac insufficiency. Pharmaceutical compositions comprising a compound of Formula I and methods of treating conditions such as hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis, or water retention are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.